SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
hesr1461-sup-0001-AppendixSA1.pdfapplication/PDF204KAppendix AS1: Author Matrix.
hesr1461-sup-0002-AppendixSA2.docxWord document76KAppendix AS2: Demographic and Clinical Characteristics of U.S. Noncontinuously (<10 Months/Year) Medicaid-Enrolled Children.
hesr1461-sup-0003-AppendixSA3.docxWord document46KAppendix AS3: Predictive Margins of Second-Generation Antipsychotic use among Continuously (≥10 Months/Year), Noncontinuously (<10 Months/Year), and All (1–12 Months/Year) Medicaid-Enrolled U.S. Children.
hesr1461-sup-0004-AppendixSA4.docxWord document30KAppendix AS4: Frequencies and Rates of Diagnosis and Second-Generation Antipsychotic (SGA) Treatment among U.S. Medicaid-Enrolled Children: Three- to Five-Year Olds.
hesr1461-sup-0005-AppendixSA5.docxWord document31KAppendix AS5: Frequencies and Rates of Diagnosis and Second-Generation Antipsychotic (SGA) Treatment among U.S. Medicaid-Enrolled Children: Six- to Eleven-Year Olds.
hesr1461-sup-0006-AppendixSA6.docxWord document31KAppendix AS6: Frequencies and Rates of Diagnosis and Second-Generation Antipsychotic (SGA) Treatment among U.S. Medicaid-Enrolled Children: Twelve- to Eighteen-Year Olds.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.